Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
532905 On Other Exchanges
Symbol
Exchange
532905 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

saamya biotech india ltd (532905) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SAAMYA BIOTECH INDIA LTD (532905)

Related News

No related news articles were found.

saamya biotech india ltd (532905) Related Businessweek News

No Related Businessweek News Found

saamya biotech india ltd (532905) Details

Saamya Biotech (India) Limited, a biotechnology company, focuses on the manufacture and marketing of biopharmaceuticals and recombinant protein products in India and Malaysia. The company also plans to manufacture pharmaceutical ingredients. In addition, it markets drug intermediates and raw materials. The company has an agreement with a European technology development company for technology transfer of fermentation products; and Arch Pharmalabs Ltd. for marketing of products. Saamya Biotech (India) Limited was incorporated in 2002 and is based in Hyderabad, India.

Founded in 2002

saamya biotech india ltd (532905) Top Compensated Officers

Chairman, Joint Managing Director and Chief F...
Total Annual Compensation: 300.0K
Chief Executive Officer, Managing Director, E...
Total Annual Compensation: 300.0K
Compensation as of Fiscal Year 2015.

saamya biotech india ltd (532905) Key Developments

Saamya Biotech (India) Limited expected to report Q3 2016 results on February 12, 2016. This event was calculated by Capital IQ (Created on November 20, 2015).

Saamya Biotech (India) Limited expected to report Q3 2016 results on February 12, 2016. This event was calculated by Capital IQ (Created on November 20, 2015).

Saamya Biotech (India) Limited Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2015

Saamya Biotech (India) Limited reported unaudited earnings results for the second quarter and six months ended September 30, 2015. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 76,707,236 against INR 0 a year ago. Profit from operations from other income, interest and exceptional items was INR 2,756,612 against INR 861,413 a year ago. Loss from ordinary activities before and after tax was INR 1,782,474 against INR 871,656 a year ago. Net loss for the period was INR 1,782,474 against INR 881,656 a year ago. Basic and diluted earnings per share were INR 0.07 against INR of 0.04 a year ago. For the six months, the company reported net sales/income from operations (net of excise duty) of INR 144,021,942 against INR 0 a year ago. Profit from operations from other income, interest and exceptional items was INR 5,148,266 against INR 1,763,700 a year ago. Loss from ordinary activities before and after tax was INR 4,190,674 against INR 1,830,962 a year ago. Net loss for the period was INR 4,190,674 against INR 1,830,962 a year ago. Basic and diluted earnings per share were INR 0.17 against INR of 0.07 a year ago.

Saamya Biotech (India) Limited to Report Q2, 2016 Results on Nov 13, 2015

Saamya Biotech (India) Limited announced that they will report Q2, 2016 results on Nov 13, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SBIL:IN 4.67 INR 0.00

532905 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 532905.
View Industry Companies
 

Industry Analysis

532905

Industry Average

Valuation 532905 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 0.4x
Price/Cash Flow 25.7x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SAAMYA BIOTECH INDIA LTD, please visit www.saamyabiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.